Skip to content
Screener

Abbott ABT Diagnostic Products — Depreciation

Other segment segments

Medical Devices
$106M+12.8%
Nutritional Products
$51M+15.9%
Established Pharmaceuticals
$25M0.0%

Similar metrics at other companies

Danaher logo
DHRDiagnostics — Depreciation
$107M+7.0%
Nucor logo
NUESteel Products — Depreciation
$54M+35.0%
Medtronic logo
MDTNeuroscience — Depreciation
$85M+18.1%
Medtronic logo
MDTCardiovascular — Depreciation
$67M+15.5%
Danaher logo
DHRBiotechnology — Depreciation
$40M+5.3%
Comfort Systems USA logo
FIXMechanical — Depreciation
$16.41M+35.7%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.92B-19.7%
Enterprise value$210.42B-10.2%
P/E33.7×+17.4×
P/S3.9×-1.4×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
(in millions)Depreciation / Three Months Ended June 30, 2026Depreciation / Three Months Ended June 30, 2025Additions to Property and Equipment / Three Months Ended June 30, 2026Additions to Property and Equipment / Three Months Ended June 30, 2025
Established Pharmaceuticals$25$25$36$39
Nutritional Products51444681
Diagnostic Products165135157166
Medical Devices10694185145
Total Reportable Segments347298424431
Other55597562
Total$402$357$499$493

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's diagnostic products — depreciation?
Abbott (ABT) reported diagnostic products — depreciation of $165M in Q2 2026.
How has Abbott's diagnostic products — depreciation changed year-over-year?
Abbott's diagnostic products — depreciation increased by 22.2% year-over-year, from $135M to $165M.
What is the long-term trend for Abbott's diagnostic products — depreciation?
Over 4 years (2021 to 2025), Abbott's diagnostic products — depreciation has grown at a -8.5% compound annual growth rate (CAGR), from $760M to $533M.
What does diagnostic products — depreciation mean?
The systematic allocation of the cost of tangible assets, such as manufacturing equipment and diagnostic instruments, over their useful lives. This non-cash expense reflects the wear and tear of the capital base used to generate segment revenue.

Ask your AI about Abbott's diagnostic products — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude